Cancer immunotherapy clinical trial shows promise, but dangers remain
A novel form of cancer immunotherapy has shown exceptional promise in a new clinical trial, with 93 percent responding positively. The treatment involves supercharging a patient’s immune cells to fight cancer then reintroducing them to the body. Source of Article